1. |
TANAKA K, IWAMOTO S, GON G, et al. Expression of Survivin and its relationship to loss of apoptosis in breast carcinomas[J]. Clin Cancer Res,2000,6(1):127-134. .
|
2. |
KARCZMAREK B B, FILIP A, WOJCIEROWSKI J, et al. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer:in situ hybridization study[J]. Folia Histochem Cytobiol,2005,43(4):237-242..
|
3. |
SAH N K, KHAN Z, KHAN G J, et al. Structural,functional and therapeutic biology of Survivin[J]. Cancer Lett,2006,244(2):164-171..
|
4. |
YONESAKA K, TAMURA K, KURATA T, et al. Small interfering RNA targeting Survivin sensitizes lung cancer cellwith mutant p53 to adriamycin[J]. Int J Cancer,2006,118(4): 812-820..
|
5. |
LI F. Survivin study: What is the next wave[J]? J cell Physio,2003,197(1):8-29..
|
6. |
AI Z, YIN L, ZHOU X, et al. Inhibition of Survivin reduces cell proliferation and induces apoptosis in human endometrial cancer[J]. Cancer,2006,107(4):746-756..
|
7. |
CHEN Y Q, LI D M, CAI Y Y, et al. The expression of Survivin messenger RNA in sputum and cancerous tissue in human lung cancer[J]. Zhonghua Jie He He Hu Xi Za Zhi,2005,28(4):225-229..
|
8. |
LI F, YANG J, RAMNATH N, et al. Nuclear or cytoplasmic expression of Survivin: what is the significance[J]? Int J Cancer,2005,114(4):509-512..
|
9. |
AKYüREK N, MEMIS L, EKINCI , et al. Survivin expression in pre-invasive lesions and non-small cell lung carcinoma[J]. Virchows Arch,2006,449(2):164-170..
|
10. |
LEE J P, CHANG K H, HAN J H, et al. Survivin,a novel anti-apoptosis inhibitor,expression in uterine cervical cancer and relationship with prognostic factors[J]. Int J Gynecol Cancer,2005,15(1):113-119..
|
11. |
VISCHIONI B, VAN DER VALK P, SPAN S W, et al. Nuclear localization of Survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer[J]. Ann Oncol,2004,15(11):1654-1660..
|
12. |
COBO M, ISLA D, MASSUTI B, et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: A phase Ⅲ trial in non-small-cell lung cancer[J]. J Clin Oncol,2007,25(19):2747-2754..
|
13. |
SORIA J C. ERCC1-Tailored ChemoTherapy in Lung Cancer: The First Prospective Randomized Trial[J]. J Clin Oncol,2007,25(19):2648-2649..
|
14. |
ALS AB, DYRSKJT L, VON DER MAASE H, et al. Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer[J]. Clin Cancer Res,2007,13(15 PT 1),4407-4414..
|
15. |
FALLENI M, PELLEGRINI C, MARCHETTI A, et al. Survivin gene expression in early-stage non-small cell lung cancer[J]. J Pathol,2003,200(5):620-626..
|
16. |
DENG H, WU R L, ZHOU H Y, et al. Significance of Survivin and PTEN expression in full lymph nodeexamined gastric cancer[J]. World J Gastroenterol,2006,12(7):1013-1017.
|